PropertyValue
?:abstract
  • Disorders involving injury to tissue stem cells that ensure normal tissue homeostasis and repair have potential to show unusually devastating clinical consequences. Acute graft-versus-host disease (aGVHD) is one condition where relatively few cytotoxic immune cells target skin stem cells to produce significant morbidity and mortality. By analogy, SARS-CoV-2 is a vector that initially homes to pulmonary stem cells that preferentially express the ACE2 receptor, thus potentially incurring similarly robust pathological consequences. In older individuals, stem cell number and/or function become depleted due to pathways independent of disease-related injury to these subpopulations. Accordingly, pathologic targeting of stem cells in conditions like aGVHD and COVID-19 infection where these cells are already deficient due to the aging process may have dire consequences in elderly individuals. A hypothesis is herein advanced that, as with aGVHD, lung stem cell targeting is a potential co-factor in explaining age-related severity of COVID-19 infection.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1038/s41374-020-00520-2
?:journal
  • Lab_Invest
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/10ccd4c5250dc5e33ae8bbb739df9b735dbcc740.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7724622.xml.json
?:pmcid
?:pmid
?:pmid
  • 33299126.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • COVID-19 and graft-versus-host disease: a tale of two diseases (and why age matters)
?:type
?:year
  • 2020-12-09

Metadata

Anon_0  
expand all